Survival signaling by the erythropoietin (Epo) receptor (EpoR) is essential for erythropoiesis and for its acceleration in hypoxic stress. A number of apparently redundant EpoR survival pathways were identified in vitro, raising the possibility of their functional specialization in vivo. Here we used mouse models of acute and chronic stress, including a hypoxic environment and β-thalassemia, to identify two markedly different response dynamics for two erythroblast survival pathways in vivo. Induction of the anti-apoptotic protein Bcl-x L is rapid but transient, whilst suppression of the proapoptotic protein Bim is slower but persistent. Similar to sensory adaptation, however, the
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Survival signaling by the erythropoietin (Epo) receptor (EpoR) is essential for erythropoiesis and for its acceleration in hypoxic stress. A number of apparently redundant EpoR survival pathways were identified in vitro, raising the possibility of their functional specialization in vivo. Here we used mouse models of acute and chronic stress, including a hypoxic environment and β-thalassemia, to identify two markedly different response dynamics for two erythroblast survival pathways in vivo. Induction of the anti-apoptotic protein Bcl-x L is rapid but transient, whilst suppression of the proapoptotic protein Bim is slower but persistent. Similar to sensory adaptation, however, the Bcl-x L pathway 'resets', allowing it to respond afresh to acute stress superimposed on a chronic stress stimulus. Using 'knock-in' mouse models expressing mutant EpoRs, we found that adaptation in the Bcl-x L response is due to adaptation of its upstream regulator Stat5, both requiring the EpoR distal cytoplasmic domain. We conclude that survival pathways show previously unsuspected functional specialization for the acute and chronic phases of the stress response. Bcl-x L induction provides a 'stop-gap' in acute stress, until slower but permanent pathways are activated. Further, pathological elevation of Bcl-x L may be the result of impaired adaptation, with implications for myeloproliferative disease mechanisms.
Introduction
Basal red cell production, as well as its acceleration by hypoxic stress 1 , require the hormone Erythropoietin (Epo). Epo exerts its effect by activating its receptor, EpoR, on the surface of erythroid progenitors 2 . Colony-forming unit-erythroid (CFU-e) progenitors and their immediate proerythroblast and basophilic erythroblast progeny are Epodependent 3 . Until recently, the rarity of these cells within hematopoietic tissue confined their biochemical study to in vitro culture systems, where they were found to undergo apoptosis when deprived of Epo 4 . It was therefore suggested that Epo regulates erythropoietic rate through the number of erythroid progenitors it rescues from apoptosis 4 .
Recently, we 5 and others 6, 7 made use of cell-surface markers to identify maturationspecific erythroblast subsets directly within freshly isolated mouse hematopoietic tissue 5 , including the Epo-responsive ProE (proerythroblasts, CD71 high Ter119 medium ) and EryA (early basophilic erythroblasts, CD71 high Ter119 high FSC high ). This approach confirmed the central role of apoptosis in the erythropoietic stress response, showing that a substantial fraction of the early erythroblast compartment, particularly splenic ProE and EryA, undergo apoptosis in vivo in the normal basal state. Stress-induced high Epo levels suppress apoptosis and consequently promote early erythroblast expansion and an increase in erythropoietic rate 5 .
Although a number of EpoR-activated survival pathways have been identified [8] [9] [10] [11] [12] , relevance to erythropoiesis in vivo was documented for only a few, largely through gene 'knockout' studies revealing abnormal basal or stress erythropoiesis 8, [13] [14] [15] [16] . Importantly, it is unknown how multiple survival pathways integrate in vivo to provide a coherent For personal use only. on October 24, 2017. by guest www.bloodjournal.org From erythropoietic stress response, and whether the large number of survival pathways represents redundancy or functional specialization. The study of these pathways in vivo, now made possible with the advent of flow-cytometric techniques [5] [6] [7] 17 , may assist in answering this question.
We recently investigated the role of the death receptor Fas, and its ligand, FasL, which are co-expressed by early erythroblasts and suppressed by EpoR signaling in vivo 5, 18, 19 . We found that, in addition to regulating cell survival, this pathway stabilizes basal erythropoiesis and accelerates its response to stress 20 . Therefore, anti-apoptotic pathways may have system-level functions that are not apparent from their anti-apoptotic effects in culture. Here we set out to investigate two apoptotic regulators of the Bcl-2 protein family that are targeted by EpoR signaling, the anti-apoptotic protein Bcl-x L , and the pro-apoptotic Bim protein. EpoR-activated Stat5 induces Bcl-x L 8,23 synergistically with GATA1, a major survival pathway in erythroblasts 21,22 24 . Bcl-x L -/mice die in utero of anemia, and Bcl-x L -/-ES cells fail to contribute to erythropoiesis in chimeric mice 25 . In a Stat5-deficient mouse 26 , reduced Bcl-x L in early erythroblasts results in ineffective erythropoiesis and anemia 13 . Severe ineffective erythropoiesis in adult erythroblasts conditionally-deleted for Bcl-x L 15 is corrected if mice are also deleted for the pro-apoptotic proteins Bax and Bak 27 , suggesting that the requirement for Bcl-x L in erythropoiesis is due to its anti-apoptotic effect. Further, using conditional deletion for Bcl-x L , it was found that it mediates over half the anti-apoptotic effect of EpoR signaling in early erythroblasts 28 .
In spite of the clear role for Bcl-x L in basal erythropoiesis, it is not known whether it is upregulated by Epo during stress. Elevated erythroblast Bcl-x L was implicated in For personal use only. on October 24, 2017. by guest www.bloodjournal.org From polycythemia vera 29, 30 , suggesting it has the potential to enhance erythroblast survival and erythropoiesis above the basal rate 30 .
We contrasted Bcl-x L with Bim, a BH3-only pro-apoptotic Bcl-2 family protein 31 .
Bim downregulation is a key component of survival signaling by cytokines and oncoproteins in hematopoietic progenitors 32, 33 . EpoR signaling in vitro was recently shown to decrease Bim mRNA 11, 34 and enhance ERK-mediated degradation of the Bim protein 34 . Like Bcl-x L , in addition to EpoR signaling, Bim suppression is also mediated by GATA-1, via its transcriptional target LRF 35 . LRF -/mice die in utero secondary to severe erythroblast apoptosis, partly rescued by Bim deletion 35 . In spite of the clear role for Bim suppression in erythroblast survival, it is not known whether this pathway participates in the stress response.
Here we used intracellular multiparameter flow-cytometry to measure Bcl-x L and Bim in stage-specific erythroblasts directly in erythropoietic tissue of fetal and adult mice as they are undergo differentiation and respond to stress in vivo. We found a similar, highly dynamic activation of the Bim and Bcl-x L survival pathways in the fetus that was dependent on both developmental day and erythroblast differentiation stage. These pathways diverge, however, in the adult, where their contrasting dynamic responses suggest a clear segregation of function during the acute and chronic phases of the stress response.
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Materials and Methods
Mice Stat5 -/mice were obtained from Dr. Lothar Hennighausen, (NIDDK, Bethesda, MD). β-thalassemia mice and the ts-VHL -/mice were described previously 5 . Bim -/mice:
B6.129S1-Bcl2l11 tm1.1Ast /J (stock #004525) were purchased from Jackson Laboratories (Bar Harbor, ME). EpoR-H and EpoR-HM mice were obtained from Dr. Jim Ihle, St. Jude Children's Research hospital, Memphis, TN. 36 In all experiments, mice were matched for the same background strain and embryonic age. For low oxygen chamber experiments, Balb/C male littermates of 6 to 11 weeks of age were used. All experiments were conducted in accordance with animal protocol A-1586 approved by the University of Massachusetts Medical School IACUC committee.
Erythropoietic stress
Recombinant human Epo (Epoetin alfa, Amgen, Thousand Oaks, CA) was injected subcutaneously in a total volume of 150 µl in sterile isotonic saline. Reduced atmospheric oxygen treatment was conducted using the BioSpherix Achamber (BioSpherix, Lacona, NY). Hypoxia was achieved by displacing oxygen with nitrogen at normal atmospheric pressure. Temperature, humidity and carbon dioxide readings were monitored.
Flow-cytometry
was performed on freshly explanted fetal liver, bone-marrow or spleen, as described 5, 18 .
Please see Supplementary Methods for additional detail.
Results

Erythroid developmental delay in Stat5 -/embryos
The definitive erythropoietic lineage generates enucleated red cells and first begins in the murine fetal liver on embryonic day 11.5 (E11.5). Using cell surface markers CD71 and Ter119, we divided fresh fetal liver into a developmental sequence of increasingly mature subsets S0 to S5 37 ( Fig 1A) . Most S0 cells (≥70%) are erythroid progenitors at the colony-forming unit stage (CFU-e), just preceding the onset of Epo/EpoR dependence that takes place at the transition from S0 to S1 37 . Subsets S1 to S5 are composed entirely of Epo-dependent erythroid progenitors and precursors. S1 contains CFU-e, S2 contain proerythroblasts, and S3 to S5 contain increasingly mature erythroblasts 37 . Between E11.5 and E14.5, fetal liver cell number increases 1000-fold, principally as a result of increasing numbers of mature erythroblasts 18 ( Fig 1A) . We previously showed that these rapid changes are associated with apoptosis whose rate varies with both differentiation stage and developmental day 18 .
Given this dynamic picture, we characterized the developmental and maturationstage-specific expression of Bcl-x L and Bim in wild-type and Stat5 -/mice (Fig 1) . Stat5 -/mice 38 are anemic in utero leading to perinatal death, a similar but more severe phenotype to that of the hypomorphic Stat5 mice 8, 26 . CD71/Ter119 profiles on sequential developmental days showed delayed progression from the S1 to S3 ( Fig 1A,B , Fig S1) .
Specifically, on E12.5, the S1 subset contained only 10% of wild-type fetal liver cells, but 35% of the Stat5 -/fetal liver cells (p<0.005), while the more mature S3 subset contained ≥ 60% of wild-type, but only 20% Stat5 -/fetal liver (p=0.005). This pattern was not due to delayed expression of Ter119 or CD71, as evident from cell size analysis of the S1 and For personal use only. on October 24, 2017. by guest www.bloodjournal.org From S3 subsets using the flow-cytometric forward scatter parameter, which was unaltered for cells in each respective subset (not shown). The slow appearance of S3 cells in the Stat5 -/fetal liver suggests that absence of Stat5 signaling causes a delay in maturation of early (S1) to later (S3/S4-5) erythroid stages in the fetal liver. This effect may be due to the known functions of Stat5 in iron uptake 39, 40 and in anti-apoptosis 8, 13, 23 and may underlie the previously noted reduced cellularity of the Stat5 -/fetal liver 40 . Of note, S3 cells in E11.5 fetal liver are likely to contain yolk sac cells, which become numerically negligible, compared with definitive lineage cells, in subsequent developmental days 18, 37 .
Bcl-x L and Bim expression in fetal liver is differentiation-stage and embryonic-day dependent
We assessed Bcl-x L and Bim protein expression using intracellular flow-cytometry ( Fig 1C,D) , employing an anti-Bcl-x L antibody that we previously verified for its specificity 13 ( Fig S2) , and an anti-Bim antibody whose specificity we verified using Bim -/spleen erythroblasts ( Fig S3) . Consistent with previous findings in vitro 22, 23 , Bcl-x L expression was low in S0-S2, increasing with differentiation ( Fig 1C, D, upper panels). In addition,
Bcl-x L expression was highly dependent on developmental day, with high levels in S0-S2 on E11.5, decreasing rapidly in the same subsets with embryonic age (Fig 1D, upper panel).
Bim expression was also dependent on both differentiation stage and embryonic day. Bim expression increased significantly with the transition from S0 to S1, with the onset of Epo and EpoR dependence 37 . The increase was of both the long (Bim L ) and extra-long (Bim EL ) transcripts ( Fig S4A, p<0 .001) and in the Bim protein ( Fig 1D, lower For personal use only. on October 24, 2017. by guest www.bloodjournal.org From panel, p<0.0001). This raised the possibility that Bim induction may be the cause of EpoR dependence. However, we found no significant differences in Epo dependence or in the sensitivity of Bim -/fetal liver erythroid progenitors to Epo using a CFU-e assay in vitro ( Fig S4B) .
Bim protein expression peaks in S1 and is gradually suppressed with erythroid differentiation, reaching its lowest values in mature erythroblasts ( Fig 1D, lower panel) . In addition, for a given maturation subset, Bim is lowest on E11.5, peaking on E12.5, and decreasing in older embryos ( Fig 1D) . The developmental-age-dependent changes in Bcl-x L and Bim are consistent with similar changes in apoptosis, cell number and Fas expression 18 .
Bim and Bcl-x L expression in fetal liver are regulated by Stat5
The rapidly changing expression of Bim and Bcl-x L during E11.5-E12.5 ( Fig 1D) , and the developmental delay in the Stat5 -/fetal liver ( Fig 1A,B , Fig S1) , together impede our ability to assess the role of Stat5 in regulating Bim and Bcl-x L expression. However, CD71/Ter119 profiles, Bim and Bcl-x L expression stabilize at E13.5, and the Stat5 -/fetal liver profile approaches that of wild-type embryos ( Fig 1D, Fig 1A,B ). We therefore compared Bim and Bcl-x L expression in Stat5 -/fetal liver and wild-type littermates on E13.5-E14.5 ( Fig 1E, Fig S4C,D) .
Bcl-x L expression in the Stat5 -/fetal liver was 1.5 to 2 fold lower in the early erythroblast subsets S1 (p=0.01), S2 (p=0.03) and S3 (p=0.002). Bim levels in Stat5 -/fetal liver were 30% and 40% higher, respectively, in the S3 and S4/5 subsets (p<0.01), suggesting Stat5 regulates its expression. For comparison, we also assessed expression of the erythroblast apoptotic regulators Fas and FasL in the Stat5 -/fetal liver. We found For personal use only. on October 24, 2017. by guest www.bloodjournal.org From no significant difference in Fas expression between Stat5 -/embryos and wild-type littermates ( Fig S5) .
Bcl-x L is rapidly induced in adult early erythroblasts in response to a single Epo injection
To investigate adult erythropoietic tissue, we use cell-surface markers CD71 and Ter119, as in the fetal liver, together with the forward-scatter parameter. The contours of the adult flow-cytometric CD71/Ter119 histogram differ from those of the fetal liver ( Fig   2B, Fig 1A) . We subdivide adult erythroid cells into subsets ProE, EryA, EryB and EryC 5,17 ( Fig 2B) . These correspond approximately, to proerythroblasts, early and late basophilic erythroblasts and polychromatic/orthochromatic erythroblasts, respectively 5 .
With this methodology, we examined Bcl-x L expression in response to Epo. A single subcutaneous Epo injection (300 U/ 25 g) results in a rapid increase in serum Epo, which peaks by 6 hours, persists for 24 hours and declines to baseline by 36 hours (Fig 2A) .
We assessed changes in Bcl-x L in freshly explanted bone-marrow and spleen erythroblasts at the indicated time-points ( Fig 2C,D) . In control uninjected or salineinjected mice, Bcl-x L levels are lowest in ProE, increasing gradually with maturation and reaching 6-fold higher levels in the most mature, EryC subset ( Injected Epo altered this pattern, causing a further induction of Bcl-x L expression in all erythroblast subsets ( Fig 2C,D) . The largest and most rapid increase was in the earliest subsets, where basal Bcl-x L levels are lowest. Thus, Bcl-x L induction peaked 5 fold within 16 hours of Epo injection in splenic ProE (p=0.0006) and 3 fold by 18 hours in splenic EryA, where it reached its highest expression levels (p=0.0009) ( Fig 2C,D) .
We also carried out a dose/response curve in vivo, examining peak Bcl-x L in splenic EryA at 18 hours following injection of various Epo doses ( Fig 2E) . Half the maximal response was obtained when injecting 3 U/ 25 g, estimated to result in a serum concentration of 0.3 U/ml, or ~10 fold increase in serum Epo.
Upregulation of the Bcl-x L protein in spleen EryA was associated with increased
Bcl-x L mRNA with a similar time course. There was a lower absolute level of the Bcl-x L mRNA in bone-marrow ( Fig 2F) .
Bim expression in adult basal and stress erythropoiesis
We examined Bim expression in adult spleen and bone-marrow, freshly explanted at the indicated time-points following either saline or Epo injection (300 U/ 25 g). Bim expression is highest in the ProE subset, declines with differentiation and reaches a quarter of its ProE level in EryC ( Fig 3A,B) . In response to Epo, Bim levels decreased further in all subsets ( Fig 3A-C) , with the largest decline in bone-marrow and spleen ProE progenitors, where they fell 1.5 to 2 fold (p<0.00001).
Importantly, in most subsets the time course of Bim suppression in response to
Epo injection was much slower, and more prolonged, than the Bcl-x L response. Maximal Bim suppression was reached at 72 hours post-injection, by which time Bcl-x L induction had peaked and returned to baseline ( Fig 3C) .
We also examined Bim mRNA in sorted bone-marrow ProE and EryA of mice injected with Epo. Like the Bim protein, both Bim L and Bim EL decreased by approximately
The erythroblast response to reduced atmospheric oxygen
The modulation of erythroblast Bim and Bcl-x L by Epo in vivo suggested that they may play a role in the physiological stress response. To test this, we placed mice in a reduced oxygen environment in which partial oxygen pressure was reduced to 11% for up to 5 days (Fig 4) . Epo levels in blood plasma rose in the first 24 hours from a basal level of 12 mU/ml, to a peak of 29 mU/ml (p=0.001). This high Epo level was sustained until day 3. On days 4 and 5 Epo began to decline to a new lower plateau of 18 mU/ml ( Fig 4A) .
The hematocrit response was rapid, rising from 51.5% to 56% in the first 24 hours, and reaching a sustained plateau of 57% ( Fig 4B) . This rapid initial increase is likely in part to be due to plasma volume adjustment in response to hypoxia 41, 42 .
We examined the response to hypoxia of specific erythroblast subsets in freshly explanted tissue ( Fig 4C-I) . The results shown are from 23 pooled experiments, with at least 6 mice per time-point. During the first 3 days, there was an increase in the absolute numbers of spleen ProE and EryA erythroblasts, reaching new plateaus that were 4 and 3 fold higher than basal values, respectively ( Fig 4C,D) . This increase was associated with a marked and significant decrease in apoptosis, with the number of Annexin V + cells declining from 55% to 32% (p=0.002) and 42% to 30% (p=0.001) in the ProE and EryA, respectively ( Fig 4E) .
The response of erythroblast Bim, Fas and Bcl-x L to reduced atmospheric oxygen
Given the clear changes in ProE and EryA apoptosis, we investigated their expression of the apoptotic regulators Fas, Bim and Bcl-x L . We previously showed that Fas expressed by spleen ProE and EryA decreases in response to a number of acute For personal use only. on October 24, 2017. by guest www.bloodjournal.org From and chronic erythropoietic stress conditions. Maximal Fas suppression is reached within 24 to 48 hours and is maintained for the duration of the stress stimulus ( Fig 4F) 5, 20 .
The Bcl-x L response was rapid and transient, its expression peaking by 18 hours in both ProE and EryA, and then rapidly dipping below baseline by 24 hours, in spite of the persisting high Epo levels ( Fig 4G) . The response of Bim, by contrast, was slower, reaching maximal suppression at 48 hours, with low levels maintained for the duration of high Epo levels (Fig 4H,I) .
Response of the Bim and Bcl-x L pathways to chronic erythropoietic stress
We went on to assess the Bim and Bcl-x L response to chronic erythropoietic stress. The Bcl-x L expression in the ProE/ EryA-C subsets in either spleen or bonemarrow was unaltered by 3 distinct erythropoietic stress conditions: pregnancy at midgestation, chronic anemia due to β-thalassemia 43 , and chronic erythrocytosis due to tissue-specific deletion of the von Hippel-Lindau gene that results in elevated Epo (ts-VHL -/-) 44 (Fig 5A) . Plasma Epo is elevated to 30 mU/ml and 220 mU/ml in the ts-VHL -/and β-thalassemia mice, respectively ( Fig S7) , a concentration range sufficient for upregulation of Bcl-x L in acute stress (Fig 4) . Further, we have previously shown that cell surface Fas and FasL are downregulated in the same chronic stress models 5 .
Unlike Bcl-x L , Bim expression in the β-thalassemia mice was suppressed in all erythroblast subsets ( Fig 5B) , to levels similar to those seen in response to an acute Epo injection ( Fig 3B) .
The Bcl-x L response to an 'acute on chronic' stress stimulus
The transience of the Bcl-x L response to stress is reminiscent of sensory systems that undergo adaptation, such as neutrophil chemotaxis or sensory neural adapting For personal use only. on October 24, 2017. by guest www.bloodjournal.org From systems. These systems respond to a change in the stimulus, rather than to absolute stimulus levels 45 . We therefore asked whether the desensitization of the Bcl-x L pathway to chronic stress was permanent, or whether an acute change in the level of stress, superimposed on a chronic stress stimulus, would re-stimulate Bcl-x L induction.
We injected β-thalassemia mice with Epo at 300 U/ 25 g, and examined Bcl-x L expression at 18 hours post-injection. We found a clear induction in Bcl-x L in all erythroblast subsets in the β-thalassemia mice, closely resembling that of control mice in the bone-marrow, and only a little short of the wild-type response in the spleen ( Fig 5C) .
Therefore, while the Bcl-x L response to chronic stress is desensitized, it responds rapidly to new changes in stress superimposed on the chronic stress levels.
To further define the Bcl-x L response to stress, we examined mice injected with Epo (300 U/ 25 g) daily for 3 consecutive days, and measured the Bcl-x L response at 18 hours following each injection ( Fig 5D) . The Bcl-x L response to the second and third Epo injections was either absent or diminished compared with the first injection ( Fig 5D) .
Therefore, a new increase in Epo that occurs close to a previous episode of stress does not elicit Bcl-x L upregulation. This experiment suggests that the Bcl-x L response to acute stress is followed by a refractory period of at least 24 hours during which Bcl-x L fails to respond further to new changes in Epo or stress.
Stat5 activation in vivo undergoes adaptation
We asked whether adaptation in the Bcl-x L stress response is due to adaptation in Stat5, its upstream regulator. We examined the time course of Stat5 activation in vivo following Epo injection (300 U/ 25 g), using intracellular flow-cytometry in freshly explanted spleen ( Fig 6A) . We validated the specificity of the anti-phospho-Stat5 antibody to the phosphorylated Y694 C-terminal residue of Stat5 ( Fig S8) . The number of ProE and EryA containing active, phosphorylated Stat5 (p-Stat5) increased rapidly following Epo injection, peaking by 30 minutes, but declining rapidly to a lower level by 6 hours ( Fig   6A) . Of note, plasma Epo peaked at 6 hours (Fig 2A) , suggesting the decline in p-Stat5 is intrinsic to the p-Stat5 response and not due to declining Epo.
Signal adaptation may be due to negative feedback 46, 47 . p-Stat5-mediated transcriptional activation of SOCS family proteins results in feedback inhibition of the Jak2 and Stat5 response 48 . This negative regulation in part depends on SOCS protein binding to phosphotyrosines on the activated EpoR cytoplasmic domain 2 . To investigate the possibility that Stat5-mediated negative feedback is responsible for p-Stat5 adaptation, we investigated two 'knock-in' mouse models expressing the EpoR mutants EpoR-H and EpoR-HM 36 , both lacking the negative regulatory distal portion of the EpoR cytoplasmic domain containing 7 of its 8 phosphotyrosines, including SOCS family docking sites 2 . In EpoR-HM, the remaining Y343, a Stat5 docking site, is mutated to phenylalanine 36 . The EpoR-H mouse has a mildly elevated basal hematocrit. The EpoR-HM mouse has a mild basal anemia and a deficient stress response 36 .
We tested the response of freshly harvested fetal liver erythroblasts from EpoR-H, EpoR-HM and wild-type embryos to continuous stimulation with Epo for up to 6 hours in vitro. The time course of response of wild-type erythroblasts was similar to that of adult erythroblasts in vivo (Fig 6A,B) . The peak p-Stat5 response to Epo stimulation in EpoR-HM erythroblasts was 15% of the response in wild-type or EpoR-H mice, in agreement with previous results 49 . In EpoR-H erythroblasts, peak p-Stat5 was similar to that of the wild-type response, though baseline p-Stat5 was higher. In both EpoR-HM and EpoR-H, duration of the initial p-Stat5 peak was prolonged substantially ( Fig 6B) . These findings suggested that the distal EpoR cytoplasmic domain, likely through binding to Stat5induced SOCS family proteins, is responsible for curtailing the p-Stat5 response.
The Bcl-x L and Bim stress responses in EpoR-H and EpoR-HM mice
The finding that the p-Stat5 signal undergoes adaptation (Fig 6A,B) suggests it may be responsible for the adaptation in the Bcl-x L response. To test this, we asked whether failure of p-Stat5 adaptation in the EpoR-H mouse ( Fig 6B) would prevent adaptation of the Bcl-x L response.
We therefore injected EpoR-H mice with Epo (300 U/ 25 g) and examined the resulting induction of Bcl-x L . The peak Bcl-x L response was closely similar to that of matched wild-type control mice (Figures 6C, S9A ). There was little increase in Bcl-x L in EpoR-HM mice, consistent with p-Stat5 as the principal regulator of the Bcl-x L stress response ( Figures 6C, S9A ). Importantly, there was a failure of adaptation of the Bcl-x L response in EpoR-H mice. Bcl-x L levels remained elevated well above their initial baseline at 36 and 48 hours post-injection in spleen ProE, and at 36 hours in EryA and EryB (p<0.005, Fig 6D) , even though Bcl-x L levels in wild-type mice ( Fig 6D) and serum Epo (Fig 2A) had returned to baseline. This strongly suggests that adaptation in the Bclx L response requires the EpoR distal cytoplasmic domain and is most likely a result of adaptation in the p-Stat5 response, also dependent on this domain ( Fig 6B) .
Bim expression was suppressed in EpoR-HM mice in response to a single Epo injection (300 U/ 25 g). However, suppression was less efficient than in wild-type mice, by a small but statistically significant amount ( Figures 6E, S5B, p=0 .03 and p=0.001 in ProE For personal use only. on October 24, 2017. by guest www.bloodjournal.org From and EryA, respectively). These results suggest that, in addition to Stat5, other pathways, likely ERK, regulate EpoR-mediated Bim suppression 34 .
The p-Stat5 response to an 'acute on chronic' stress stimulus
Although Bcl-x L expression is not elevated in chronic stress, it is induced in response to an acute stimulus superimposed on the chronic stress stimulus ( Fig 5C) . We similarly examined the p-Stat5 response to chronic and 'acute on chronic' stress stimuli.
We found no increase in the level of p-Stat5 in ProE freshly isolated from β-thalassemic mice ( Fig 6F, upper panel) , in spite of the chronically elevated plasma Epo in these mice ( Fig S7) . A single injection of β-thalassemic mice with Epo (300 U/ 25 g) however, resulted in a rapid increase in p-Stat5 in both β-thalassemic mice and in matched control mice ( Fig 6F, lower panels) . These data further support the adaptation in the p-Stat5 response as the cause of adaptation in the Bcl-x L response to stress.
Discussion
We examined Bim suppression and Bcl-x L induction, two EpoR-activated erythroblast survival pathways in fetal and adult basal and stress erythropoiesis. Their analysis in vivo revealed previously unsuspected functional specialization of EpoRpathways to either the chronic or acute phases of the stress response. Bcl-x L induction behaves like a classical sensory adapting pathway, being insensitive to the prevailing level of stress, and instead responding only to changes in stress level. Adaptation allows
Bcl-x L to provide a stop-gap at the onset of stress that rapidly rescues early erythroblasts from apoptosis, until slower but persistent stress pathways, such as Bim or Fas suppression, are activated. Mechanistically, we suggest that adaptation in the Bcl-x L response is the result of adaptation in the response of p-Stat5, its upstream regulator.
Regulation of Bim and Bcl-x L expression in early vs. late erythroblasts
We delineated the expression pattern of both Bim and Bcl-x L proteins throughout erythroid maturation in adult and fetal tissue in vivo. The basal pattern observed in the absence of stress is one of low Bcl-x L and high Bim in early erythroblasts, inverting with differentiation so that in mature erythroblasts Bim levels are low, and Bcl-x L levels are high ( Fig 7A) . These results are consistent with previous reports of increasing in Bcl-x L with differentiation in vitro 22, 23 , and with the increase in Bcl-x L and decrease in Bid and Bax transcripts with the transition from early to late erythroblasts in murine bone-marrow 6 . Together with our previous findings of high Fas and FasL in early, but not late, apoptosis are seen in early erythroblasts but not in late erythroblasts during normal fetal and basal adult erythropoiesis in vivo 5, 18, 20, 50 (Fig 4E) , and was recently suggested as responsible for the sensitivity of early erythroblasts to irradiation 6 .
Bcl-x L is regulated by both GATA-1 and EpoR-activated Stat5 24 . Similarly, Bim suppression is regulated by EpoR-activated ERK 34 and by GATA-1-induced LRF 35 . In addition, we found that Bim is regulated by EpoR-activated Stat5 in fetal liver and, to a lesser extent, in the adult (Figures 1E, 6E , and S9B). Lower Bcl-x L in the S1-S3 subsets of the Stat5 -/fetal liver, and in EpoR-HM mice in the basal state, support the role of Stat5 in the induction of erythroid Bcl-x L 8, 13, 23 . The role of Stat5 is especially notable, however, in the Bcl-x L stress response, which is absent in the EpoR-HM mice ( Fig 6C) .
Based on these expression patterns, we propose that EpoR and GATA-1mediated regulation of Bim and Bcl-x L are largely segregated to the early and late erythroblast compartments, respectively ( Fig 7A) . Specifically, the underlying, largely stress-insensitive gradual increase in Bcl-x L and gradual suppression of Bim with differentiation is likely to be mediated by GATA-1. Superimposed on this pattern are Epomediated, stress-dependent adjustments that modulate Bcl-x L induction and Bim suppression in early erythroblasts (Figures 2, 3, 7A) . Thus, only the apoptosis-prone CFU-e, proerythroblasts and early basophilic erythroblasts (='early erythroblast compartment') are dependent on EpoR signaling for survival in the basal state. Further, during hypoxic stress, it is principally the early erythroblast compartment that is Epo responsive and undergoes expansion as a result of reduced apoptosis 5, 18, 20, 50 (Fig 4E) .
The susceptibility of the early erythroblast compartment to apoptosis is precisely the For personal use only. on October 24, 2017. by guest www.bloodjournal.org From characteristic that gives plasticity to the erythropoietic system, allowing the level of EpoR signaling to determine erythropoietic rate. Peak Bcl-x L protein and mRNA levels in response to stress were attained in EryA erythroblasts in spleen, a subset that is both Epo responsive, and that expands dramatically in response to erythropoietic stress 5 . The more prominent response of spleen EryA compared with bone-marrow EryA is consistent with the known role of the spleen as the primary site of stress erythropoiesis.
Using Fas and FasL-mutant mice, we found recently that the Epo-mediated Fas suppression accounts for ~30% of the early erythroblast expansion in stress 19 . Bim The finding that EpoR induces Bcl-x L in early erythroblasts in vivo is consistent with extensive literature showing Bcl-x L induction in response to EpoR signaling in vitro (e.g. 8, 13, [21] [22] [23] [24] 28 ). Our findings, however, also suggest that, following its initial activation, the EpoR-Stat5-Bcl-x L pathway becomes refractory to high Epo. This property may explain the failure of one report to detect Bcl-x L induction in bone-marrow erythroblasts that were previously subjected to expansion in vitro under prolonged stress-like growth conditions 51 . The same group reported Bcl-x L induction in response to Epo in subsequent work 11, 52 . Importantly, our results show that Stat5-regulated Bcl-x L expression in vivo varies with differentiation stage, with embryonic day, and with the At the onset of stress the speed of response is paramount, a property that is unimportant during the chronic maintenance phase. Here we find that Bcl-x L upregulation in response to hypoxia is significantly faster than Bim or Fas suppression (Fig 4) . In addition, the Bclx L response undergoes rapid adaptation, which makes it insensitive to the prevailing absolute level of stress. However, like other classical sensory adapting mechanisms, it is re-activated as soon as a new change in stress takes place. In this way, the dynamic range of the Bcl-x L response is extended, allowing a rapid response to changes in stress irrespective of the baseline stress levels.
In addition to Bcl-x L , other survival pathways, including Bim and Fas suppression, likely contribute to the acute phase of stress. Indeed, Bim is suppressed with fast kinetics in spleen ProE in response to high Epo ( Fig 3C) ; and we recently showed that the Fas suppression pathway accelerates the stress response 20 . Maximal Bim and Fas suppression, however do not occur until 48 to 72 hours from the onset of stress, by which time Bcl-x L has returned to its baseline value. Therefore, Bcl-x L likely enhances erythroblast survival during an early phase of stress prior to the full establishment of the stress response. The EpoR is therefore capable of generating both a persistent signal, For personal use only. on October 24, 2017. by guest www.bloodjournal.org From giving rise to persistent suppression of Bim and Fas, and a rapidly adapting signal, responsible for the adaptation of the Bcl-x L response ( Fig 7B) .
The picture that emerges is of several survival pathways, potentially some as yet to be characterized, with specialization for either the acute or chronic phases of stress, 
Mechanism of adaptation in the Bcl-x L response
We identified adaptation in the p-Stat5 response in erythroblasts in vivo and suggest this to be the mechanism of adaptation in the Bcl-x L response. Both p-Stat5 and
Bcl-x L respond similarly to an 'acute on chronic' stress stimulus, a response typical of other biological adapting systems like sensory adaptation or neutrophil chemotaxis.
Adaptation of both p-Stat5 and
Bcl-x L depend on the distal domain of the EpoR, a previously documented negative regulatory domain that contains docking sites for the Stat5-induced SOCS family of negative regulators 2 (Fig 7C) . Negative feedback is a well-documented mechanism of adaptation in sensory systems 46, 47 . Stat5 transcriptionally activates SOCS inhibitors that feed back to limit Jak2 and Stat5 activation 48 . Though well-documented, the precise effect of this pathway on the p-Stat5 signal was not previously investigated. Here we found that in EpoR-H mice that lack this feedback inhibition, peak p-Stat5 signal intensity is not higher than in wild-type. However, the duration of the peak is prolonged ( Fig 6D) . Therefore, p-Stat5-mediated negative feedback is likely responsible for the adaptation of both the p-Stat5 and Bcl-x L responses.
Implications for myeloproliferative disease mechanisms
The rapid adaptation of the Bcl-x L response to stress raises the possibility that prolonged periods in which Bcl-x L is elevated may be harmful. Indeed, persistently elevated levels of Bcl-x L are characteristic of Polycythemia Vera and other myeloproliferative syndromes 29, 30, 54 . High Bcl-x L was suggested as a cause of Epoindependent erythroid differentiation in Polycythemia Vera and of the apoptosis resistance of other myeloproliferative syndromes and neoplasms 29, 54, 55 . Our results, supported by recent reports of SOCS protein inactivation in myeloproliferative disease 56, 57 , suggest that impairment of p-Stat5 and Bcl-x L adaptation may contribute to their prolonged activation. Together these point to the importance of adaptation in the Bcl-x L response as a homeostatic and tumor-suppressive mechanism.
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There are no conflicts of interest to declare by any of the authors. subsets in the fetal liver 37 . Dead cells were excluded using LIVE/DEAD viability dye.
B
Summary of analysis performed as in 'A'. Data-points are each mean ±SEM of 4 to 21 embryos. Statistically significant differences between wild-type and Stat5 -/subsets (indicated with a star) were found for S1 on E12.5 (p=0.002, 2-tailed t-test, unequal variance), E13.5 (p=0.00001) and E14.5 (p=0.014) and for S3 on E12.5 (p=0.005), E13.5 (p=0.00004) and E14.5 (p=0.010).
C
Representative flow-cytometry histograms for the Bcl-x L and Bim proteins in the indicated fetal liver subsets. Freshly isolated wild-type E14.5 fetal liver cells were stained with CD71, Ter119 and the LIVE/DEAD viability dye, and were then fixed, permeabilized and stained intracellularly with an anti-Bcl-x L antiserum or non-immune antiserum control ('IgG'); or with anti-Bim antibody or IgG isotype control. X-axis is in fluorescence units.
D
Bcl-x L and Bim protein levels, measured as in 'C', in fresh wild-type fetal liver subsets S0 to S4/5 at the indicated embryonic days. Data were pooled from several experiments with multiple litters. Data-points are each the median fluorescence intensity (MFI) ±SEM of 4 to 14 embryos or 6 embryos for Bcl-x L and Bim measurements, respectively. Non-specific background fluorescence, defined as the MFI of the corresponding subset stained with control IgG, was subtracted. On E13.5 and E14.5 there were significant differences between S2 and S3 (p≤0.0001), and between S3 and S4/5 (p<0.001, paired t-test). Statistically significant differences in Bim expression were found for S1 between E11.5 and E12.5 (p<0.0001, 2-tailed t-test, unequal variance). On E12.5 there were significant differences between S0 and S1 (p<0.0001), and between S1 and S3, (p<0.0001). Similar developmental patterns were observed in C57BL/6 and Balb/C backgrounds.
E
Lower Bcl-x L and higher Bim levels in E14.5 Stat5 -/embryos compared with wildtype littermate controls, at the indicated differentiation subset.
For Bcl-x L : n=11 to 21 embryos per genotype, with each symbol type representing median expression for one litter. Means ±SEM for the population are indicated.
Statistically significant differences were found for S2 (p=0.03), S3 (p=0.002, paired t-test).
For Bim: data-points are individual embryos. Mean ±SEM for the population is shown. Statistically significant differences were found for S3 and S4-5 (p<0.01, 2-tailed ttest, unequal variance). There was a significant decrease following Epo injection in Bim EL mRNA in ProE (p=0.00439, t test, unequal variance, 2 tails, all post-Epo injection data were pooled) and
EryA (p=0.013), and in Bim L mRNA in ProE (p=0.027).
The ratio of Bim L to Bim EL mRNA in Epo injected and in saline-injected mice, in the experiments described in 'D'. Data are mean ±SD; all Epo time-points were pooled for the purpose of this analysis. There were no significant changes in this ratio with Epo injection.
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F
The p-Stat5 histograms in vivo at peak response (30 minutes) following a single injection of either Epo (300 U/ 25 g) or saline, in either β-thalassemia mice or in matched wild-type controls, measured in freshly explanted spleen ProE. The p-Stat5 + gate was drawn based on the non-erythroid population in spleen (grey histograms). X-axis is in fluorescence units. 
